These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 27016893)
1. Resistance-associated mutations to HCV protease inhibitors naturally pre-existed in HIV/HCV coinfected, treatment-naïve patients. Cao Y; Bao Y; Xia W; Wu H; Wei F; Zhang Y; Zhang R; Xu X Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):597-604. PubMed ID: 27016893 [TBL] [Abstract][Full Text] [Related]
2. Resistance mutations are rare among protease inhibitor treatment-naive hepatitis C genotype-1 patients with or without HIV coinfection. Lisboa-Neto G; Noble CF; Pinho JR; Malta FM; Gomes-Gouvêa MS; Alvarado-Mora MV; da Silva MH; Leite AG; Piccoli LZ; Rodrigues FK; Carrilho FJ; Mendes-Correa MC Antivir Ther; 2015; 20(3):281-7. PubMed ID: 25279715 [TBL] [Abstract][Full Text] [Related]
3. Naturally occurring hepatitis C virus (HCV) NS3/4A protease inhibitor resistance-related mutations in HCV genotype 1-infected subjects in Italy. Vicenti I; Rosi A; Saladini F; Meini G; Pippi F; Rossetti B; Sidella L; Di Giambenedetto S; Almi P; De Luca A; Caudai C; Zazzi M J Antimicrob Chemother; 2012 Apr; 67(4):984-7. PubMed ID: 22258932 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus (HCV) protease variability and anti-HCV protease inhibitor resistance in HIV/HCV-coinfected patients. Trimoulet P; Belzunce C; Faure M; Wittkop L; Reigadas S; Dupon M; Ragnaud JM; Fleury H; Neau D HIV Med; 2011 Sep; 12(8):506-9. PubMed ID: 21410862 [TBL] [Abstract][Full Text] [Related]
5. [Determination of drug resistance mutations of NS3 inhibitors in chronic hepatitis C patients infected with genotype 1]. Şanlıdağ T; Sayan M; Akçalı S; Kasap E; Buran T; Arıkan A Mikrobiyol Bul; 2017 Apr; 51(2):145-155. PubMed ID: 28566078 [TBL] [Abstract][Full Text] [Related]
6. Naturally occurring hepatitis C virus protease inhibitors resistance-associated mutations among chronic hepatitis C genotype 1b patients with or without HIV co-infection. Cao Y; Zhang Y; Bao Y; Zhang R; Zhang X; Xia W; Wu H; Xu X Hepatol Res; 2016 May; 46(6):552-8. PubMed ID: 26355704 [TBL] [Abstract][Full Text] [Related]
7. Baseline prevalence and emergence of protease inhibitor resistance mutations following treatment in chronic HCV genotype-1-infected individuals. Nguyen LT; Gray E; Dean J; Carr M; Connell J; De Gascun C; Nguyen LA; O'Leary A; Bergin C; Hall W; Norris S Antivir Ther; 2015; 20(8):865-9. PubMed ID: 25920764 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV. Silva T; Cortes Martins H; Coutinho R; Leitão E; Silva R; Pádua E J Med Virol; 2015 Sep; 87(9):1549-57. PubMed ID: 25940586 [TBL] [Abstract][Full Text] [Related]
9. Unexpected Replication Boost by Simeprevir for Simeprevir-Resistant Variants in Genotype 1a Hepatitis C Virus. Murai K; Shimakami T; Welsch C; Shirasaki T; Liu F; Kitabayashi J; Tanaka S; Funaki M; Omura H; Nishikawa T; Sumiyadorj A; Honda M; Kaneko S Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661883 [TBL] [Abstract][Full Text] [Related]
10. Exploring resistance pathways for first-generation NS3/4A protease inhibitors boceprevir and telaprevir using Bayesian network learning. Cuypers L; Libin P; Schrooten Y; Theys K; Di Maio VC; Cento V; Lunar MM; Nevens F; Poljak M; Ceccherini-Silberstein F; Nowé A; Van Laethem K; Vandamme AM Infect Genet Evol; 2017 Sep; 53():15-23. PubMed ID: 28499845 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1. Costa VD; Delvaux N; Brandão-Mello CE; Nunes EP; de Sousa PSF; de Souza Rodrigues LLLX; Lampe E; do Amaral Mello FC Clin Res Hepatol Gastroenterol; 2019 Nov; 43(6):700-706. PubMed ID: 30880098 [TBL] [Abstract][Full Text] [Related]
12. NS3 protease polymorphism and natural resistance to protease inhibitors in French patients infected with HCV genotypes 1-5. Vallet S; Viron F; Henquell C; Le Guillou-Guillemette H; Lagathu G; Abravanel F; Trimoulet P; Soussan P; Schvoerer E; Rosenberg A; Gouriou S; Colson P; Izopet J; Payan C; Antivir Ther; 2011; 16(7):1093-102. PubMed ID: 22024525 [TBL] [Abstract][Full Text] [Related]